S. Taplin

Highly potent anti-SARS-CoV-2 multi-DARPin therapeutic candidates

B. Bosch, A. Lehmann, H. Binz, 2020, bioRxiv.

The functional assessment and rehabilitation programme of the UK hand and upper limb transplant service

S. Kay, D. Wilks, S. Taplin, 2020, Hand Therapy.

Hepatotoxicity with antibody maytansinoid conjugates: A review of preclinical and clinical findings

M. Walles, W. Kluwe, K. Vashisht, 2018, Journal of applied toxicology : JAT.

Nursing care strategies for the management of side effects in patients treated for colorectal cancer.

C. Blanke, S. Taplin, C. Baughman, 1997, Seminars in oncology.

Molecular Pathology Techniques in the Preclinical Development of Therapeutic Biologics

T. Flandre, S. Taplin, Stewart A Jones, 2015 .

Integrated pharmacokinetic, pharmacodynamic and immunogenicity profiling of an anti-CCL21 monoclonal antibody in cynomolgus monkeys

S. Dudal, J. Sims, G. Jarai, 2015, mAbs.

Trimetrexate: review and current clinical experience in advanced colorectal cancer.

M. Messenger, C. Blanke, S. Taplin, 1997, Seminars in oncology.